Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chron...
Q1 2026
May 13, 2026
FY 2025
Mar 26, 2026
Q4 2025
Q3 2025
Nov 5, 2025
Q2 2025
Aug 6, 2025